Chez nous (en France, ), on utilise encore beaucoup l'aspirine, en p�diatrie, en alternance avec le parac�tamol. A choisir en tre deux anti-inflammatoires (aspirine et nurofen), on prefere celui que l'on connait bien.
---- Messages d�origine ---- De: Charles Brault <[EMAIL PROTECTED]> Date: samedi, juillet 19, 2003 6:21 pm Objet: URG-L: Complications de l'AAS chronique ? > S'cuzez le ! > Y'est en mode surfing ces jours-ci > > Question : > Je sais qu'il y a beaucoup de complications avec l'spirine > Des milliers de mort annuellement ! (Je retrouve pas l'article) > > Mais quand est-il des complicaitons li� � la prise chronique de > microdose (80mg DIE) ? > > et > > Est-ce sachant que chez nous on �vite depuis longtemps l'AAS le plus > possible (Reyes Syndrome, troubles digestifs, allergies) et quel est > presque compl�tement remplac� par l'entrophen(parac�tamol) > Quant est-il en France ? > (En Alg�rie, y'en prennent encore comme de la soupe (p�diatrie > inclus) > > > Charles Brault EMT-P > > > Am J Cardiol. 2002 Mar 15;89(6):653-61. > > Underuse of aspirin in a referral population with documented coronary > artery disease. > > Califf RM, DeLong ER, Ostbye T, Muhlbaier LH, Chen A, LaPointe NA, > Hammill BG, McCants CB, Kramer JM. > > Centers for Education & Research on Therapeutics (CERTs), Duke > Clinical Research Institute, Durham, North Carolina 27715, USA. > [EMAIL PROTECTED] > > Despite substantial evidence that antiplatelet therapy saves lives > and reduces adverse events in patients with coronary artery disease > (CAD), use of the most widely available and lowest cost antiplatelet > agent, aspirin, continues to be disappointingly low. > > In a large database of patients with known CAD, we (1) explored > trends in the use of aspirin over time, (2) characterized patients > most likely to take aspirin regularly, and (3) estimated the > effectiveness of aspirin use by examining long-term outcomes. Using > patients entered in the Duke Databank for Cardiovascular Diseases, we > explored the use of aspirin from 1969 to 1999. > More than 25,000 patients were sent a questionnaire that included > several questions about medication use, including 1 question > specifically about aspirin. Patients who failed to respond to the > questionnaire received a follow-up telephone call. > > Aspirin use increased substantially over the most recent 4 years in > the study, from 59% in 1995 to 81% in 1999. Predictors of aspirin use > included younger age, male sex, being a nonsmoker, and having had a > myocardial infarction or revascularization procedure. Patients who > never took aspirin had a risk ratio for death of 1.85 compared with > patients who regularly took aspirin. > > Despite the well-known beneficial effects of aspirin, too many > patients without contraindications to aspirin fail to take it > regularly. > > The health care system currently lacks effective methods to ensure > that patients who have CAD have adequate follow-up concerning aspirin > use. > > > > __________________________________ > Do you Yahoo!? > SBC Yahoo! DSL - Now only $29.95 per month! > http://sbc.yahoo.com > > --- URG-L > Pour modifier votre adresse de courriel sur URG-L, envoyez un avis > a > [EMAIL PROTECTED] en indiquant votre nouvelle adresse ainsi > que l'ancienne et le nom de la liste. > > --- URG-L Pour modifier votre adresse de courriel sur URG-L, envoyez un avis a [EMAIL PROTECTED] en indiquant votre nouvelle adresse ainsi que l'ancienne et le nom de la liste.
